NASDAQ:MDGS
Medigus Ltd Stock News
$2.36
+0 (+0%)
At Close: May 03, 2024
CHK, BYND among premarket gainers
01:15pm, Friday, 24'th Apr 2020
Mesoblast (NASDAQ:MESO) +119% as cell therapy shows significant benefit in COVID-19 patients.Medigus (NASDAQ:MDGS) +73% on COVID-19 plan.Pluristem Therapeutics (NASDAQ:PSTI) +20% on €50 capital r
Medigus Ltd. (MDGS) (MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced the signing of a binding letter of intent with
Medigus Ltd. Announces 2019 Financial Results
10:11pm, Tuesday, 21'st Apr 2020
OMER, Israel, April 21, 2020 -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endo-surgical.
ScoutCam Inc. Closes Investment Round and Raises $948,400 at a Valuation of approximately $14.5 Million
12:00pm, Friday, 06'th Mar 2020
OMER, Israel, March 06, 2020 -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization.
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
12:21pm, Wednesday, 19'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 18) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Anavex
NVDA, ACB among premarket gainers
02:19pm, Friday, 14'th Feb 2020
BioXcel Therapeutics (NASDAQ:BTAI) +67%.Canopy Growth (NYSE:CGC) +24% on Q3 results.Blink Charging (NASDAQ:BLNK) +25%.ImmunoGen (NASDAQ:IMGN) +16% on Q4 results.Genprex (NASDAQ:GNPX) +14%.Medigus (N
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL
Medigus Signs a Non-binding MOU for the License and Sale of the MUSE™ System in the Latin America Region for $4.5 Million
12:00pm, Friday, 14'th Feb 2020
Medigus Ltd. (MDGS) (MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced the signing of a $4,000,000 non-binding MOU ag
The Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe
01:46pm, Thursday, 02'nd Jan 2020
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 31.) Aptose Biosciences Inc (NASDAQ: APT
Medigus and Intellisense Close Merger
11:30am, Thursday, 02'nd Jan 2020
Intellisense Issues 60% of its Share Capital to Medigus and ScoutCam Becomes Wholly-Owned Subsidiary of Intellisense OMER, Israel, Jan. 02, 2020 -- Medigus Ltd..
Medigus Received Payment of $1.2M as Part of the Licensing and Sale Agreement for MUSE™ in Greater China
12:00pm, Friday, 22'nd Nov 2019
Medigus Ltd. (MDGS) (MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that the second installment in the amount of
